Royal Decree 957/2020 As of 2 January 2021, observational studies of medicinal products for human use (‘OSM’) are to be regulated in Spain by Royal Decree 957/2020, which repeals the previously applicable Order SAS/3470/2009. The main purpose of Royal Decree […]
Recent investigations of the pharmaceutical sector by the competition authorities demonstrate a focus on examining a number of actions that could entail an interruption of supply or even the withdrawal of medicinal products from the market by pharmaceutical companies. Specifically, […]
On 19 January CEFI organised a seminar to deepen our understanding of vaccines in times of pandemic. Interest in the debate, reflected in the number of registrations (298) and the quality of the speakers, most of whom are at the […]
